Profile image
Senior Clinical Project Coordinator

Dr Hila Haskelberg


+61 (0)2 9385 0900
Li I; Chen AZ; Newby JM; Kladnitski N; Haskelberg H; Millard M; Mahoney A, 2022, 'The uptake and outcomes of an online self-help mindfulness programme during COVID-19', Clinical Psychologist, 26, pp. 255 - 268,
Gardner T; Schultz R; Haskelberg H; Newby JM; Wheatley J; Millard M; Faux SG; Shiner CT, 2022, 'The Effect of Adjunct Telephone Support on Adherence and Outcomes of the Reboot Online Pain Management Program: Randomized Controlled Trial', Journal of Medical Internet Research, 24,
Shiner CT; Gardner T; Haskelberg H; Li I; Faux SG; Millard M; Mahoney AEJ, 2022, 'The Uptake and Effectiveness of a Multidisciplinary Online Program for Managing Chronic Pain before and During the COVID-19 Pandemic', Pain Medicine (United States), 23, pp. 1621 - 1630,
Sharrock M; Mahoney A; Haskelberg H; Millard M; Newby J, 2021, 'The uptake and outcomes of Internet cognitive behavioural therapy for health anxiety symptoms during the COVID-19 pandemic', Journal of Anxiety Disorders
Loughnan S; Wallace M; Joubert A; Haskelberg H; Andrews G; Newby JM, 2018, 'A systematic review of psychological treatments for clinical anxiety during the perinatal period', Archives of Women’s Mental Health.
Loughnan S; Newby JM; Haskelberg H; Mahoney A; Kladnitski N; Smith J; Black E; Holt C; Milgrom J; Andrews G, 2018, 'Internet-based cognitive behavioural therapy (iCBT) for perinatal anxiety and depression versus treatment as usual: study protocol for a randomized controlled trial', Trials
Berthon-Jones N; Courtney-Vega K; Donaldson A; Haskelberg H; Emery S; Puls R, 2015, 'Assessing site performance in the Altair study, a multinational clinical trial', Trials, 16,
Haskelberg H; Mallon PWG; Hoy J; Amin J; Moore C; Phanuphak P; Ferret S; Belloso WH; Boyd MA; Cooper DA; Emery S, 2014, 'Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ ritonavir compared with standard second-line therapy', Journal of Acquired Immune Deficiency Syndromes, 67, pp. 161 - 168,
Haskelberg H; Cordery DV; Amin J; Kelleher AD; Cooper DA; Emery S, 2014, 'HLA Alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9,
Haskelberg H; Pocock N; Amin J; Ebeling PR; Emery S; Carr A, 2014, 'Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9,
Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, 7, pp. e38377,
Byakwaga H; Purcell DJ; French MA; Amin J; Lewin S; Haskelberg H; Kelleher AD; Garsia RJ; Boyd MA; Cooper DA; Emery S, 2011, 'Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4 + T-cell response: A randomized controlled trial', Journal of Infectious Diseases, 204, pp. 1532 - 1540,
Haskelberg H; Carr AD; Emery S, 2011, 'Bone turnover markers in HIV disease', AIDS Reviews, 13, pp. 240 - 250,
Smith FA; Haskelberg H; Tracey DJ; Moalem-Taylor G, 2008, 'Role of histamine H-3 and H-4 receptors in mechanical hyperalgesia following peripheral nerve injury', Neuroimmunomodulation, 14, pp. 317 - 325,